- US12479856utility2025Pharmaceutical Compounds for the Treatment of Complement Mediated Disorders0 cites
- US12338230utility2025Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Immune and Inflammatory Disorders0 cites
- US12297205utility2025Macrocyclic Compounds for Treatment of Medical Disorders0 cites
- US12239645utility2025Targeted Dosing for the Treatment of Complement Mediated Disorders0 cites
- US12162860utility2024Aryl, Heteroaryl, and Heterocyclic Pharmaceutical Compounds for Treatment of Medical Disorders0 cites
- US12139497utility2024Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Medical Disorders0 cites
- US12076319utility2024Therapeutic Regimens for Treatment of Paroxysmal Nocturnal Hemoglobinuria0 cites
- US12065459utility2024Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Complement Mediated Disorders0 cites
- US12006307utility2024Pharmaceutical Compounds for Treatment of Medical Disorders0 cites
- US11926617utility2024Aryl, Heteroaryl, and Heterocyclic Compounds for Treatment of Immune and Inflammatory Disorders0 cites
- US11814391utility2023Macrocyclic Compounds for the Treatment of Medical Disorders0 cites
- US11814363utility2023Morphic Forms of Danicopan0 cites
- US11718626utility2023Macrocyclic Compounds for Treatment of Medical Disorders0 cites
- US11708351utility2023Aryl, Heteroaryl, and Heterocyclic Pharmaceutical Compounds for Treatment of Medical Disorders0 cites
- US11649223utility2023Amino Compounds for Treatment of Immune and Inflammatory Disorders0 cites
- US11649229utility2023Amide Compounds for Treatment of Immune and Inflammatory Disorders0 cites